Cargando…
Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma
Standard treatment for patients with high-risk neuroblastoma remains multimodal therapy including chemoradiation, surgical resection, and autologous stem cell rescue. Immunotherapy has demonstrated success in treating many types of cancers; however, its use in pediatric solid tumors has been limited...
Autores principales: | Qiao, Jingbo, Liu, Junquan, Jacobson, Jillian C., Clark, Rachael A., Lee, Sora, Liu, Li, An, Zhiqiang, Zhang, Ningyan, Chung, Dai H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757561/ https://www.ncbi.nlm.nih.gov/pubmed/36525420 http://dx.doi.org/10.1371/journal.pone.0277956 |
Ejemplares similares
-
Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells
por: Clark, Rachael A., et al.
Publicado: (2020) -
Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma
por: Clark, Rachael A., et al.
Publicado: (2022) -
Combination bromo- and extraterminal domain and poly (ADP-ribose) polymerase inhibition synergistically enhances DNA damage and inhibits neuroblastoma tumorigenesis
por: Jacobson, Jillian C., et al.
Publicado: (2022) -
High-Risk Neuroblastoma: A Surgical Perspective
por: Jacobson, Jillian C., et al.
Publicado: (2023) -
Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
por: Chen, Heyu, et al.
Publicado: (2020)